DrugDashboards

Lidocaine Hydrochloride

Lidocaine Hydrochloride · LIDOCAINE HYDROCHLORIDE 5 mg/mL · Injection, Solution · Infiltration; Intravenous · Hospira, Inc.

NDC 00409-4278-01 · 25 VIAL, SINGLE-DOSE in 1 TRAY / 50 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

18 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now — FDA lists the reason as “demand increase for the drug”.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$108.02
Reported to Texas DSHS · 2026 annual filing · Pfizer Inc.

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicaid spend (2025)

$1,787
477 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.6%chance of a new FDA shortage posting for lidocaine hydrochloride (injectable) in the next 90 days

sterile injectable · 4 Class I/II recall(s) in 12 months · OAI inspection at a producing facility (24 months)

For scale: the typical drug’s chance is about 0.1% — this one is 4× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA088328
TE code
AP
Approval date
May 17, 1984
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 0143-9577-10)Jun 13, 2018
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-251-10)Jun 13, 2018
    Demand increase for the drug
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 10 mg/mL (NDC 55150-252-20)Jun 13, 2018
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 0143-9575-10)Jun 13, 2018
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-254-10)Jun 13, 2018
    Demand increase for the drug
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-255-20)Jun 13, 2018
    Demand increase for the drug
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-256-50)Jun 13, 2018
    Demand increase for the drug
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Preservative Free, Injection, 10 mg/1 mL (NDC 0143-9595-25)Jun 13, 2018
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Preservative Free, Injection, 20 mg/1 mL (NDC 0143-9594-25)Jun 13, 2018
    month 99 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-159-74)Feb 20, 2018
    Demand increase for the drug
    month 103 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-161-02)Feb 20, 2018
    month 103 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-162-05)Feb 20, 2018
    month 103 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 55150-163-30)Feb 20, 2018
    month 103 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 20 mg/1 mL (NDC 55150-165-05)Feb 20, 2018
    month 103 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride, Injection, 20 mg/mL (NDC 55150-164-02)Feb 20, 2018
    month 103 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride And Dextrose, Injection, 4 mg/1 mL (NDC 0338-0409-03)Oct 25, 2017
    month 107 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydrochloride And Dextrose, Injection, 8 mg/1 mL (NDC 0338-0411-02)Oct 25, 2017
    month 107 — 5× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-17)Oct 14, 2016
    month 119 — 6× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Xylocaine, Injection, .005 mg/1 mL; 10 mg/1 mL (NDC 63323-487-37)Oct 14, 2016
    month 119 — 6× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months
  • In shortage now — Lidocaine Hydochloride, Injection, 50 mg/5 mL (NDC 83634-653-05)Feb 22, 2012
    month 175 — 9× the typical 20-month injectable shortage · model puts 25% odds it resolves within 6 months

Recalls (this NDC)

  • Class I · TerminatedMay 3, 2021
    PFIZER, INC — Labeling: Label Mix-Up: some vials labeled to contain 0.5% Bupivacaine Hydrochloride Injection, USP may contain 1% Lidocaine HCl Injection, USP and some vials labeled to contain 1% Lidocaine HCl Injection, USP may contain 0.5% Bupivacaine Hydrochloride Injection, USP
  • Class II · OngoingAug 25, 2015
    Hospira, Inc. — Presence of Particulate Matter: particulate matter identified as iron oxide, was found embedded in the neck of glass vials.
  • Class I · TerminatedOct 16, 2014
    Hospira Inc. — Presence of particulate matter: A returned customer sample was evaluated and found to have human hair attached to a pinched area of the stopper.
  • Class I · TerminatedApr 18, 2014
    Hospira Inc. — Presence of Particulate Matter: Confirmed customer complaint that orange and black particulates, identified as iron oxide, were found embedded within the glass vial and floating in solution.
  • Class I · TerminatedSep 16, 2013
    Hospira, Inc. — Presence of Particulate Matter: Oxidized stainless steel found in vial of 1% Lidocaine Hydrochloride Injection, USP.
  • Class II · TerminatedOct 4, 2012
    Hospira, Inc. — Presence of Particulate Matter: Report of a vial containing visible particulate matter embedded in the glass wall which has the potential to dislodge resulting in the presence of particulate matter in the product.

Manufacturers of Lidocaine Hydrochloride (Injection, Solution)

LabelerStrengthFirst seenLast seen
Anthea Pharma Private LimitedLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Asclemed USA, Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Asclemed USA, Inc.LIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Camber Pharmaceuticals, Inc.LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mLJul 15, 2026Sep 3, 2026
Eugia US LLCLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Eugia US LLCLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 5 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mLJul 15, 2026Sep 3, 2026
Henry Schein, Inc.LIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mLJul 15, 2026Sep 3, 2026
Henry Schein, Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Hikma Pharmaceuticals USA Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Hospira, Inc.LIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Hospira, Inc.LIDOCAINE HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 3, 2026
Hospira, Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Lifestar Pharma LLCLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Lifestar Pharma LLCLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Medical Purchasing Solutions, LLCLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
NorthStar RxLLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mLJul 15, 2026Sep 3, 2026
NorthStar RxLLCLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
ProPharma DistributionLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 3, 2026
Sandoz Inc.LIDOCAINE HYDROCHLORIDE 10 mg/mLSep 3, 2026Sep 3, 2026
Sandoz Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLSep 3, 2026Sep 3, 2026
Sportpharm LLCLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
A-S Medication SolutionsLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
A-S Medication SolutionsLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 2, 2026
Anthea Pharma Private LimitedLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Asclemed USA, Inc.LIDOCAINE HYDROCHLORIDE ANHYDROUS 20 mg/mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationLIDOCAINE HYDROCHLORIDE 8 mg/mLJul 15, 2026Sep 2, 2026
Baxter Healthcare CorporationLIDOCAINE HYDROCHLORIDE 4 mg/mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCLIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 2, 2026
Cardinal Health 107, LLCLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Civica, Inc.LIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Civica, Inc.LIDOCAINE HYDROCHLORIDE 20 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 15 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCLIDOCAINE HYDROCHLORIDE ANHYDROUS 10 mg/mL; EPINEPHRINE BITARTRATE .005 mg/mLAug 26, 2026Sep 2, 2026
Henry Schein, Inc.LIDOCAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Lidocaine Hydrochloride — NDC 00409-4278-01," retrieved September 3, 2026, https://drugdashboards.com/drug/00409427801.

Free to cite with attribution — see how the data is put together.